VENTYX BIOSCIENCES INC. - COMMON STOCK

1.7300

07-February-25 16:45:00

15 minutes delayed

Stocks

-0.0600

-3.35%

Today's range

1.7100 - 1.8200

ISIN

N/A

Source

NASDAQ

Ventyx Biosciences to Participate in the Barclays Global Healthcare Conference

07 Mar 2022 08:00:01 By Nasdaq GlobeNewswire
Ventyx Biosciences Announces First Patient Dosed in a Phase 2 Clinical Trial of VTX002 for the Treatment of Moderate-to-Severe Ulcerative Colitis

06 Dec 2021 08:00:01 By Nasdaq GlobeNewswire
Ventyx Biosciences to Participate in Two Upcoming Investor Conferences

19 Nov 2021 08:00:00 By Nasdaq GlobeNewswire
Ventyx Biosciences Reports Third Quarter Financial Results and Provides Business Update

17 Nov 2021 16:11:04 By Nasdaq GlobeNewswire
Ventyx Biosciences Announces Closing of Upsized Initial Public Offering and Full Exercise of Underwriters’ Option to Purchase Additional Shares

25 Oct 2021 16:58:33 By Nasdaq GlobeNewswire
Ventyx Biosciences Announces Pricing of Upsized Initial Public Offering

20 Oct 2021 20:38:40 By Nasdaq GlobeNewswire

<<
<
1
2
3
4
>

I Agree NetDania's website uses cookies. By continuing browsing our website, you agree to our Cookie Policy, Privacy Policy and Terms and Conditons.